Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial
Titel:
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial
Auteur:
Knight, Jennifer M. Rizzo, J. Douglas Hari, Parameswaran Pasquini, Marcelo C. Giles, Karen E. D'Souza, Anita Logan, Brent R. Hamadani, Mehdi Chhabra, Saurabh Dhakal, Binod Shah, Nirav Sriram, Deepika Horowitz, Mary M. Cole, Steve W.